Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults

NCT00333398 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1359

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free
BIOLOGICAL: CSL Trivalent Inactivated Influenza Vaccine with Thimerosal
BIOLOGICAL: Placebo with Thimerosal

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)